期刊文献+

布加综合征病因的临床和实验研究初探 被引量:16

Preliminary study on etiology of Budd-Chiari syndrome through clinic and experiment
原文传递
导出
摘要 目的初步探讨布加综合征(BCS)的病因。方法分析2001年3月至2009年5月109例BCS根治术中所见。对11例隔膜型BCS患者下腔静脉和(或)肝静脉隔膜和8例下肢深静脉血栓形成(DVT)的血栓成分进行比较。免疫组化方法研究两者组织中13型转化生长因子受体(TGF-βR)、血小板衍化生长因子受体(PDGFR)、内皮素-1(ET-1)、Ⅷ因子相关抗原(FⅧ-rAg)、α1-抗胰蛋白酶、铁蛋白的表达情况。结果本组除4例为下腔静脉肿瘤和1例为下腔静脉外纤维条索压迫所致BCS外,其余104例均为下腔静脉和(或)肝静脉隔膜或血栓形成所致。2例原为下腔静脉血栓,根治清除血栓1年和7年后复发,再次手术发现为下腔静脉新生隔膜。3例下腔静脉节段性闭塞者术中可见陈旧血栓向隔膜演变的过程。8例下腔静脉隔膜在肝静脉开口下方。隔膜和血栓组织均含纤维母细胞、中性粒细胞,均有肉芽组织及新生血管等病理改变。相关的细胞因子TGF-βR、PDGFR、ET-1、FⅧ-rAg、铁蛋白在两者组织中的表达率分别为72.3%和50.0%(P〉0.05),45.5%和100%(P〈0.05),100%和0(P〈0.05),90.9%和12.5%(P〈0.05),72.3%和100%(P〉0.05)。结论BCS患者的隔膜和血栓有着相似的组织细胞成分和细胞因子表达,隔膜和血栓或为病变的不同阶段。 Objective To investigate the etiology of Budd-Chiari syndrome (BCS) preliminarily. Methods The clinical findings of radical surgery of 109 cases with BCS from March 2001 to May 2009 were analyzed. The pathological components of membranous tissue (MT) from inferior vena cava (IVC) or hepatic vein (HV) of BCS patients were compared with that of thrombus from deep venous thrombosis (DVT), as well as the expression of transforming growth factor β receptor ( TGF-βR), platelet derived growth factor receptor ( PDGFR), endothelin ( ET-1 ), factor Ⅷ related antigen ( FⅧ-rAg), ferritin and α1-antitrypsin in MTs and thrombus through immunohistochemical method. Results One hundred and four cases of BCS were due to IVC and/or HV membrane or thrombosis except that 4 cases due to IVC tumor or 1 case due to compression of fiber trabs. The new-formed IVC membrane was found in 2 recurred cases whose IVC thrombus was excised before 1 year and 7 years. The development from organized thrombus to MT was found in 3 cases of segmental obstruction of IVC. The IVC membrane located below HV outlet was in 8 cases. Both MTs and thrombus had the pathological components such as fibroblast, neutrophil, granulation tissue, newly- formed blood vessels and so on under the light microscope. The expressions of TGF-βR, PDGFR, ET-1, FⅧ-rAg, and ferritin in MTs and thrombus were as follows : MT 72. 3% , thrombus 50. 0% ( P 〉 0. 05 ) ; MT 45.5%, thrombus 100% ( P 〈 0.05 ) ; MT 100%, thrombus 0 ( P 〈 0. 05 ) ; MT 90.9%, thrombus 12.5% (P〈0.05); MT72.3%, thrombus 100% (P〉0.05). Conclusions The membranous tissues and thrombus have the similar homogeneity and cytokines expression. The membrane and thrombus may be different pathological phases.
出处 《中华外科杂志》 CAS CSCD 北大核心 2010年第8期569-572,共4页 Chinese Journal of Surgery
关键词 肝静脉血栓形成 受体 转化生长因子Β 受体 血小板源生长因子 Hepatic vein thrombosis Receptors, transforming growth factor beta Receptors, platelet-derived growth factor
  • 相关文献

参考文献14

  • 1Hirooka M,Kimura C.Membranous obstruction of the hepatic portion of the inferior vena cava.Surgical correction and etiological study.Arch Surg,1970,100:656-663.
  • 2Simson IW.Membranous obstruction of the inferior vena cava and hepatocellular carcinoma in South Africa.Gastroenterology,1982,82:171-178.
  • 3Yamamoto S,Yokoyama T,Takeshige K,et al.Budd-Chiari syndrome with obstruction of the inferior vena cava.Gastroenterology,1968,54:1070-1084.
  • 4Takeuchi J,Takada A,Hasumura Y,et al.Budd-Chiari syndrome associated with obstruction of the inferior vena cava.A report of seven cases.Am J Med.1971.51:11-20.
  • 5Okuda K.Membranous obstruction of the inferior vena cava:etiology and relation to hepatocellular carcinoma.Gastroenterology,1982,82:376-379.
  • 6Terabayashi H,Okuda K,Nomura F,et al.Transformation of inferior vena caval thrombosis tomembranous obstruction in a patient with lupus anticoagulant.Gastroenterology,1986,91:219-224.
  • 7李艳奎,张小明,沈晨阳,李清乐,张韬,袁链,李伟,赵克强.膜性梗阻型布-加综合征隔膜和机化血栓组织中相关细胞因子表达的研究[J].中华普通外科杂志,2008,23(8):618-621. 被引量:7
  • 8Wang ZG,Jones RS.Budd-Chiari Syndrome.Curr Probl Surg,1996,33:83-211.
  • 9李晓强,段鹏飞,钱爱民,桑宏飞.布加综合征根治术后复发再手术11例分析[J].中华普通外科杂志,2005,20(5):274-275. 被引量:14
  • 10Kage M,Arakawa M,Kojiro M,et al.Histopathology of membranous obstruction of the inferior vena cava in the Budd.Chiari syndrome.Gastroenterology,1992,102:2081-2090.

二级参考文献16

  • 1张小明,张学民,李伟,沈晨阳,汪忠镐.直视下布加综合征根治术13例体会[J].中华普通外科杂志,2004,19(9):537-539. 被引量:12
  • 2汪忠镐,马颂章,王仕华,张逢吉,龚庆成.布加综合征根治性矫正术式的探讨(附37例报告)[J].中华胸心血管外科杂志,1995,11(3):132-134. 被引量:33
  • 3张小明,李清乐.布加综合征诊治现状[J].中国医学科学院学报,2007,29(1):25-28. 被引量:29
  • 4Matsui S, Ichida T, Watanabe M, et al. Clinical features and etiology of hepatocellular carcinoma arising in patients with membranous obstruction of the inferior vena cava: in reference to hepatitis viral infection. J Gastroenterol Hepatol, 2000, 15: 1205-1211.
  • 5Simson IM. Membranous obstruction of the inferior vena cava and hepatocellular carcinoma in South Africa. Gastroenterology, 1982, 82: 171-175.
  • 6Kew MC, Hodkinson HJ. Membranous obstruction of the inferior vena cava and its causal relation to hepatocenular carcinoma. Liver International ,2006,26 : 1-7.
  • 7Okuda K. Membranous obstruction of the inferior vena cava. J Gastmenterol Hepatol, 2001,16 : 1179-1183.
  • 8Terabayashi H, Okuda K, Nomura F, et al. Transformation of inferior vena caval thrombosis to membranous obstruction in a patient with the lupus anticoagulant. Gastroenterology, 1986,91 : 219 -224.
  • 9Albrecht S, Kahn HJ. Immunohistochemistry of intravascular papillary endothelial hyperplasia. J Cutan Pathol, 1990, 17: 16-21.
  • 10Bini A, Jr Fenoglio J, Sobel J, et al. Immunochemical characterization of fibrinogen, fibrin Ⅰ, and fibrin Ⅱ in human thrombi and atherosclerotic lesions. Blood, 1987, 69 : 1038-1045.

共引文献28

同被引文献144

引证文献16

二级引证文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部